Global Fund awards Tanzania $111 million grant for ITNs

Tanzania will receive an $111 million grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria for insecticide-treated nets (ITNs) to be used in the country's fight against malaria, Ray Chambers, U.N. special envoy for malaria, said at a meeting in Dar es Salaam, Tanzania, on Monday, Reuters reports.

Chambers said the money will be allocated to purchase 14 million ITNs "for universal coverage" and that the "Global Fund representatives ... have committed to sign the Round 8 Grant agreement next week and they are ready to disburse the money."

Convincing people in Africa to use the ITNs is a challenge, according to Chambers, who is in Tanzania with WHO Director General Margaret Chan to highlight the country's success in combatting malaria. "The average, it appears, in Africa, (is that) one out of two people will not sleep under a net unless they are reminded, encouraged, there are inspirational messages on the radio," he said (Obulutsa, 8/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A promising new strategy for malaria drug development